 |
| Louis Massaia |
Weber Shandwick has hired Louis Massaia, executive VP/chief creative officer at Havas Health & You, as its first CCO for the North America healthcare group.
He will work on key accounts such as Moderna and Novartis and spearhead the creative strategy for the health team.
During his 25-year career, Massaia worked as EVP/creative director at both Saatchi & Saatchi Wellness and GSW/Palio and SVP/CD at The CementBloc.
He has handled clients such as Pfizer, Johnson & Johnson, Narcan, Celgene and Arena Pharma.
 |
| Angela Mears |
Weber Shandwick also has promoted Angela Mears to the New York chief creative officer slot.
The 11-year veteran of the Interpublic unit had been global executive creative director for the western region (Los Angeles, San Francisco and Seattle).
She led creative for McDonald’s, Airbnb, Genentech, Columbia Sportswear and VMware.
Joy Farber Kolo, North America CEO, said the bar for creative that moves minds, culture and business has never been higher.
She “can’t wait to see the impact these powerhouse leads bring to these pivotal roles.”
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
